Douglas R. Rank

Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program

John E. Mazuski, Leanne B. Gasink, J. Armstrong et al. · Clinical Infectious Diseases · 2016 · 385 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

CANVAS 1 and 2: Analysis of Clinical Response at Day 3 in Two Phase 3 Trials of Ceftaroline Fosamil versus Vancomycin plus Aztreonam in Treatment of Acute Bacterial Skin and Skin Structure Infections

H. David Friedland, Tanya O’Neal, Donald Biek et al. · Antimicrobial Agents and Chemotherapy · 2012 · 69 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +14

Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia

Douglas R. Rank, H. David Friedland, Joseph B. Laudano · Journal of Antimicrobial Chemotherapy · 2011 · 53 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Single- and Multiple-Dose Study To Determine the Safety, Tolerability, and Pharmacokinetics of Ceftaroline Fosamil in Combination with Avibactam in Healthy Subjects

Todd Riccobene, Sheng Su, Douglas R. Rank · Antimicrobial Agents and Chemotherapy · 2013 · 52 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Evaluation of the Effect of a Supratherapeutic Dose of Intravenous Ceftaroline Fosamil on the Corrected QT Interval

Todd Riccobene, Ludmyla Rekeda, Douglas R. Rank et al. · Antimicrobial Agents and Chemotherapy · 2013 · 15 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11